Enzo Biochem Statistics

Total Valuation

Enzo Biochem has a market cap or net worth of $22.60 million. The enterprise value is -$14.56 million.

Market Cap	22.60M
Enterprise Value	-14.56M

Important Dates

The last earnings date was Monday, March 17, 2025, after market close.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	Nov 15, 2024

Share Statistics

Enzo Biochem has 52.40 million shares outstanding. The number of shares has increased by 3.81% in one year.

Current Share Class	52.40M
Shares Outstanding	52.40M
Shares Change (YoY)	+3.81%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	20.27%
Owned by Institutions (%)	21.68%
Float	36.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.77
Forward PS	n/a
PB Ratio	0.48
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.04, with a Debt / Equity ratio of 0.07.

Current Ratio	3.04
Quick Ratio	2.59
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-50.44

Financial Efficiency

Return on equity (ROE) is -12.94% and return on invested capital (ROIC) is -9.73%.

Return on Equity (ROE)	-12.94%
Return on Assets (ROA)	-7.46%
Return on Invested Capital (ROIC)	-9.73%
Return on Capital Employed (ROCE)	-19.74%
Revenue Per Employee	$213,926
Profits Per Employee	-$156,706
Employee Count	136
Asset Turnover	0.35
Inventory Turnover	2.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.04% in the last 52 weeks. The beta is 0.77, so Enzo Biochem's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	-66.04%
50-Day Moving Average	0.53
200-Day Moving Average	0.93
Relative Strength Index (RSI)	34.29
Average Volume (20 Days)	93,293

Short Selling Information

The latest short interest is 314,061, so 0.60% of the outstanding shares have been sold short.

Short Interest	314,061
Short Previous Month	311,230
Short % of Shares Out	0.60%
Short % of Float	0.86%
Short Ratio (days to cover)	2.75

Income Statement

In the last 12 months, Enzo Biochem had revenue of $29.09 million and -$21.31 million in losses. Loss per share was -$0.41.

Revenue	29.09M
Gross Profit	13.02M
Operating Income	-9.94M
Pretax Income	44.73M
Net Income	-21.31M
EBITDA	-8.56M
EBIT	-9.94M
Loss Per Share	-$0.41

Full Income Statement

Balance Sheet

The company has $40.30 million in cash and $3.14 million in debt, giving a net cash position of $37.16 million or $0.71 per share.

Cash & Cash Equivalents	40.30M
Total Debt	3.14M
Net Cash	37.16M
Net Cash Per Share	$0.71
Equity (Book Value)	46.62M
Book Value Per Share	0.89
Working Capital	35.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.96 million and capital expenditures -$784,000, giving a free cash flow of -$15.75 million.

Operating Cash Flow	-14.96M
Capital Expenditures	-784,000
Free Cash Flow	-15.75M
FCF Per Share	-$0.30

Full Cash Flow Statement

Margins

Gross margin is 44.74%, with operating and profit margins of -34.15% and -73.25%.

Gross Margin	44.74%
Operating Margin	-34.15%
Pretax Margin	-26.12%
Profit Margin	-73.25%
EBITDA Margin	-29.44%
EBIT Margin	-34.15%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of $0.10, which amounts to a dividend yield of 23.19%.

Dividend Per Share	$0.10
Dividend Yield	23.19%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-3.81%
Shareholder Yield	19.38%
Earnings Yield	-94.30%
FCF Yield	-69.67%

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on October 21, 2004. It was a forward split with a ratio of 1.05:1.

Last Split Date	Oct 21, 2004
Split Type	Forward
Split Ratio	1.05:1

Scores

Enzo Biochem has an Altman Z-Score of -4.03 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.03
Piotroski F-Score	3